ask="10.55"
ask_size="100"
average_daily_volume="213747"
bid="9.63"
bid_size="300"
book_value="2.66"
change="+0.05"
change_from_200_day_moving_average="2.04"
change_from_50_day_moving_average="1.42"
change_from_52_week_high="-1.58"
change_From_52_week_low="3.55"
change_in_percent="+0.48%"
close="10.55"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.30"
ebitda="-117.58M"
eps_estimate_current_year="-2.04"
eps_estimate_next_quarter="-0.58"
eps_estimate_next_year="-1.71"
ex_dividend_date="N/A"
float_shares="15519000"
high="10.62"
high_52_weeks="12.13"
last_trade_date="1/5/2017"
last_trade_price="10.55"
last_trade_size="53582"
last_trade_time="4:00pm"
low="10.28"
low_52_weeks="7.00"
market_capitalization="193.07M"
moving_average_200_day="8.51"
moving_average_50_day="9.13"
name="Akebia Therapeutics
Inc."
notes="N/A"
one_year_target_price="16.00"
open="10.50"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+23.91%"
percent_change_from_50_day_moving_average="+15.51%"
percent_change_from_52_week_high="-13.03%"
percent_change_from_52_week_low="+50.71%"
previous_close="10.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.95"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18300000"
short_ratio="13.24"
stock_exchange="NGM"
symbol="AKBA"
volume="312719"
weeks_range_52="7.00 - 12.13"
